早期甲泼尼龙冲击治疗与活动性系统性红斑狼疮长期损伤累积的预防:Lupus-Cruces-Bordeaux队列的倾向性评分分析
本研究基于Lupus-Cruces-Bordeaux队列的观察性数据,纳入随访5至10年的469例系统性红斑狼疮(SLE)患者,其中99例(21%)接受甲泼尼龙冲击(MP)治疗。经倾向性评分校正的Cox模型显示,MP与主要结局(不可逆器官损伤或任何原因死亡)风险显著降低相关(校正HR 0.63,95%CI 0.40-0.98,p=0.044),5年时效应亦显著(校正HR 0.61,95%CI 0.37-0.98,p=0.042)。分层分析表明获益仅限于中重度活动组(SLEDAI≥6),且主要体现在狼疮相关和糖皮质激素相关损伤项目。
要点
- 早期MP与SLE患者长期损伤或死亡风险降低独立相关(校正HR 0.63)。
- MP的获益主要见于中重度活动(SLEDAI≥6)患者。
- 获益主要体现在狼疮相关和糖皮质激素相关损伤项目。
核心结论
- 早期甲泼尼龙冲击治疗可降低活动性SLE患者长期不可逆器官损伤或死亡的风险,尤其在中重度活动患者中。
研究设计与样本
- 观察性研究,使用Lupus-Cruces-Bordeaux队列的临床诊疗数据,并扩展纳入历史Lupus Cruces队列患者,随访时间≥5年且至多10年。
主要发现
- 共纳入469例患者,99例(21%)接受MP。
- 倾向性评分校正Cox模型显示,MP与主要结局风险显著降低相关(校正HR 0.63,95%CI 0.40-0.98,p=0.044)。
- 5年时MP效应亦显著(校正HR 0.61,95%CI 0.37-0.98,p=0.042)。
- 分层分析显示获益仅限于中重度活动组(SLEDAI≥6),且主要体现于狼疮相关和糖皮质激素相关损伤项目。
临床怎么用
- 对于中重度活动的SLE患者,可考虑早期使用甲泼尼龙冲击治疗以降低长期损伤累积风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Methylprednisolone pulses (MP) help achieve prolonged remission in patients with moderate-severe systemic lupus erythematosus (SLE), but their potential effect in reducing damage accrual has not been addressed. This study aims to disclose whether MP given within the first year of follow-up could impact long-term damage accrual. METHODS: Observational study using clinical care data of patients included in the Lupus-Cruces-Bordeaux cohort, expanded with patients from the historic Lupus Cruces cohort, with a follow-up time ≥5 years and up to 10 years. The primary outcome was the presence of irreversible organ damage or death for any cause during the whole follow-up time; the early outcome was set at 5 years. In addition, specific SLE-related and GC-related, cardiovascular and other forms of damage were also assessed as outcomes. The effect of MP was evaluated by Kaplan-Meier survival curves and propensity score (PS)-adjusted Cox models, in the whole cohort and in groups of mild activity (Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) <6) and moderate-severe activity (SLEDAI≥6). RESULTS: 469 patients were included, of whom 99 (21%) received MP. In the PS-adjusted Cox models, MP was associated with a significantly reduced risk for the primary outcome (adjusted HR 0.63, 95% CI 0.40 to 0.98, p=0.044), with the effect being significant also at 5 years (adjusted HR 0.61, 95% CI 0.37 to 0.98, p=0.042). The stratified analyses revealed that the benefit was restricted to the group of patients with moderate/severe activity and mainly in lupus and glucocorticoid-related damage items. CONCLUSIONS: This study supports the role of the early MP in reducing long-term damage accrual and death, especially among patients with moderate/severe activity.
引用
- Marín-García B, Dueña-Bartolomé L, Paredes-Ruiz D, et al. Early methylprednisolone pulses and prevention of long-term damage accrual in active systemic lupus erythematosus: a propensity score analysis of the Lupus-Cruces-Bordeaux cohort. RMD Open. 2026. PMID: 42031508. doi:10.1136/rmdopen-2025-006518
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。